Tulsian told CNBC-TV18, "I have been maintaining my positive view on Apollo Hospitals, in fact there was one positive news, one contradictory news that promoters have subscribed the shares at a lower price, since that clarification has come that the subscription was made when the face value was Rs 10 and accordingly the share issue - price was adjusted to about Rs 370 and odd, if you take the case of this company, 8000 beds and about 55-56 hospitals and one of the largest hospital in Asia. So obviously, the kind of growth they have been consistently posting and maybe the performance going ahead, probably I am keeping my positive view on the stock and expect maybe about 20% rise from hereon in next 6-8 months time."
